E2F3 and liver cancer: Our results demonstrated for the first time that Tiliroside had an anticancer activity for liver cancer as a novel CAXII inhibitor, reduced stemness and differentiation, and could modulated apoptotic axis E2F1/E2F3-Caspase3.